Briefcase

Tylenol caplets being recalled over complaints of sickness, odor

TRENTON, N.J. – Tylenol caplets are again being recalled by Johnson & Johnson after some consumers were sickened by ingesting the pills or smelling a musty or moldy odor on the bottles.

Johnson & Johnson’s McNeil Consumer Healthcare unit received some complaints from people who reported nausea, stomach pain, vomiting and diarrhea after taking the pills, a spokeswoman said Monday.

This makes 13 recalls in barely a year by the health care giant. It’s the fifth time that the New Brunswick, N.J.-based company has recalled nonprescription medicines because of consumer complaints about an unpleasant odor.

The moldy odor is thought to be due to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole, McNeil said in a statement.

Associated Press

Input sought on ‘say on pay’

WASHINGTON – Federal regulators have proposed rules giving shareholders at all public companies a nonbinding vote on executive compensation packages.

The Securities and Exchange Commission on Monday opened to public comment the so-called say-on-pay proposals. They also would give shareholders an advisory vote on the “golden parachute” deals that executives get when their companies are acquired by others in mergers.

The SEC could formally adopt the new rules sometime after the 30-day comment period.

Associated Press

GD unit wins Boeing contract

CHARLOTTE, N.C. – General Dynamics Armament and Technical Products unit will receive a $17 million contract from the Boeing Co. to produce components and spare parts for Boeing’s C-17 Globemaster III aircraft.

General Dynamics Armament and Technical Products and Boeing have been working on composites for the aircraft for 20 years.

Associated Press

Earnings roundup

• Citigroup Inc., one of the worst-hit banks during the financial crisis, posted its third straight quarterly profit, in a sign that major banks and their customers are starting to find their footing. The bank earned $2.15 billion, or 7 cents per share, in the three months ending in September. The results beat analysts’ expectations by a penny. The profit came after the bank took back $1.97 billion it had previously set aside for bad loans.

• Apple: Apple Inc. said net income for the most recent quarter soared 70 percent on strong sales of iPhones, though iPad sales fell short of expectations. Apple’s net income rose to $4.3 billion, or $4.64 per share, from $2.5 billion, or $2.77 per share, in the same period last year. Revenue jumped 67 percent to $20.3 billion from $12.2 billion last year. Both revenue and net income were record amounts for Apple.

• IBM: IBM Corp. said its net income rose 12 percent as it wrung more out of its services and software divisions and gets a lift from a new mainframe computer. IBM earned $3.59 billion, or $2.82 per share, in the July to September period, compared to $3.21 billion, or $2.40 per share, in the same period last year. Analysts on average expected $2.75 per share, according to a poll by Thomson Reuters. Revenue rose 3 percent to $24.27 billion. Analysts had expected $24.13 billion.